Hyperfine enrolls first patient in PRISM PMR study

Hyperfine (HYPR) announced plans for clinical use expansion into the operating room environment, advancing its mission to make brain MRI more accessible across a diversity of care settings. The company plans to establish a foothold in the neurosurgical operating setting by launching a new study to build a body of clinical evidence for Swoop system use in neurosurgical procedures. PRISM PMR is designed to further collect data and optimize the Swoop system’s real-world clinical utility in the operating room. The study will evaluate the pre- and post-procedure use of portable MRI across a diverse range of neurosurgical procedures, including its ability to detect post-operative complications, such as stroke and bleeding, and how it can be best integrated into the surgical workflow to accelerate discharge and recovery. The study has enrolled its first patients. It is being conducted over three months at the Atlas Surgery Center in Buffalo, New York.